Autopsy report · NCT05147584

Trans-abdominal Fetal Pulse Oximetry

“Device Modifications and Relocation of Principal Investigator”

The sponsor’s own words in the registry.

Life of this trial

• Registered 8 months before it started.
• Ran for about 1 year 4 months before it stopped.
• 31 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Raydiant Oximetry, Inc.

Sponsor type

Industry

Conditions

Fetal Hypoxia; Fetal Distress; Fetal Acidemia; Fetal or Neonatal Effect of Complication of Labor

Interventions

Dual fetal oxygen sensors

Participants

31

Sites

1

Countries

United States

Trials that died the same way

• Changes in Muscle Activation When Carrying Backpacks
  “Change of a principal investigator” (71% match in meaning)
• A Study of Oral L-citrulline in Sickle Cell Disease
  “Principal Investigator moved to another institution” (67% match in meaning)
• A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease
  “Principal Investigator has moved to another institution” (66% match in meaning)
• Effect of Music Therapy on Cognitive Recovery
  “Principal Investigator left facility” (65% match in meaning)
• Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma
  “Principal investigator transition” (64% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.